From the Trenches: A Spotlight Interview with Larry Farese
The Spotlight had a chance to sit down with longtime Robins Kaplan trial attorney and mediator Larry Farese for a good old-fashioned story telling session.
View ArticleThe IRS Says “Nice Try.” Case Illustrations of Unsuccessful Valuation Efforts
In the context of valuation, legal professionals have at times utilized creative efforts to shield clients from tax exposure. It is perhaps unsurprising therefore that whether the focus involves art, a...
View ArticleValuation: The “Eye of the Beholder” Causes Disputes
The need to value closely held corporations and associated real estate frequently arises in the context of estate administration. The value of such assets, however, is often fogged by the differing...
View ArticleANDA Approvals
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA. table.tableizer-table {...
View ArticleANDA Litigation Settlements
This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to the Hatch-Waxman Act....
View ArticleGeneric Launches
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications....
View ArticleNew ANDA Cases
This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same...
View ArticleBiogen Int’l GmbH v. Amneal Pharmaceuticals LLC
Case Name: Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC, Civ. No. 17-823 (MN), 2020 WL 5549084 (D. Del. Sept. 16, 2020) (Noreika, J.) Drug Product and Patent(s)-in-Suit: Tecfidera® (dimethyl...
View ArticleNoven Pharm., Inc. v. Amneal Pharms. LLC
Case Name: Noven Pharm., Inc. v. Amneal Pharms. LLC, No. 18-cv-00699 (D. Del. Sept. 2, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Minivelle® (estradiol); U.S. Patents Nos. 9,833,419 (“the...
View ArticleNovartis Pharms. Corp. v. Accord Healthcare Inc.
Case Name: Novartis Pharms. Corp. v. Accord Healthcare Inc., No. 18-1043-KAJ (D. Del. August 10, 2020) (Jordan, J.) Drug Product and Patent(s)-in-Suit: Gilenya® (fingolimod); U.S. Patent No. 9,187,405...
View ArticleSun Pharm. Indus. Ltd. v. Saptalis Pharms., LLC
Case Name: Sun Pharm. Indus. Ltd. v. Saptalis Pharms., LLC, No. 18-648-WCB, 2020 WL 5077412 (D. Del. Aug. 6, 2020) (Bryson, J.) Drug Product and Patent(s)-in-Suit: Riomet® (metformin HCl); U.S. Patent...
View ArticleBristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc.
Case Name: Bristol-Myers Squibb Co. v. Aurobindo Pharma USA Inc., No. 17-374-LPS (Consolidated), 2020 WL 4500226 (D. Del. Aug. 5, 2020) (Stark, J.) Drug Product and Patent(s)-in-Suit: Eliquis®...
View ArticleIBSA Institut Biochimique, S.A. v. Teva Pharms. USA, Inc.
Case Name: IBSA Institut Biochimique, S.A. v. Teva Pharms. USA, Inc., No. 2019-2400 (Fed. Cir. July 31, 2020) (Circuit Judges Prost, Reyna, and Hughes presiding; Opinion by Prost, C.J.) (Appeal from D....
View ArticleTakeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc.
Case Name: Takeda Pharms. U.S.A., Inc. v. Mylan Pharms. Inc., No. 2020-1407, -1417 (Fed. Cir. July 31, 2020) (Circuit Judges Prost, Newman, and Hughes presiding; Opinion by Prost, C.J.; Dissent by...
View ArticleConservation Easement Deductions: How Recent Tax Law Developments Have...
I. Introduction A recent development in tax law has created a new, fertile area for recovery of losses via legal malpractice litigation. For years, tax attorneys recommended conservation easements to...
View ArticleDon’t Stop the Music: The Intersection Between Insurance and The Music...
Several industries have been severely hit by the COVID-19 pandemic, and the music industry is certainly no exception. Although many artists have found creative ways to monetize their craft, such as...
View ArticleInterview with Uzma Saghir, Senior Corporate Counsel at Liberty Mutual
Tell me about your current role.I work on the corporate side, for two main clients – Procurement and Meeting Management and Event Strategy. For Procurement, Liberty spends over $12 billion a year with...
View ArticleFacing Novel Legal Issues Concerning Facial Recognition Technology in 2020
“Beware the Kodak,” warned TheHartfordDaily Courant in July 1888. “The sedate citizen can’t indulge in any hilariousness without incurring the risk of being caught in the act and having his photograph...
View ArticleANDA Approvals
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA. table.tableizer-table {...
View ArticleANDA Litigation Settlements
This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to the Hatch-Waxman Act....
View Article
![ONEW – KAKERA -Unmei no Piece- – EP [iTunes Plus M4A]](http://is1-ssl.mzstatic.com/image/thumb/Music221/v4/d0/fb/86/d0fb86a5-ba60-4bea-41fb-7f54c125f518/VEATP-45908.jpg/296x296bb.webp)
/pic9814888.png)
